Synaptic Pharmaceutical Corporation
Records under this name other than patents Synaptic Pharmaceutical Corporation holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Back to Synaptic Pharmaceutical Corporation
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,220,775 | Compound Useful for the Treatment of Neuropathic Pain Formerly held Term ended Term ended Apr 9, 2025 · High confidence | Term ended | Term ended Apr 9, 2025 | High confidence |
| US 6,936,607 | 2,4,6-Triaminopyrimidines for the Treatment of Depression And/Or Anxiety Formerly held Term ended Term ended Aug 7, 2023 · High confidence | Term ended | Term ended Aug 7, 2023 | High confidence |
| US 7,166,635 | 3-Imino-2-Indolones for the Treatment of Depression And/Or Anxiety Formerly held Term ended Term ended May 26, 2022 · High confidence | Term ended | Term ended May 26, 2022 | High confidence |
| US 6,654,856 | System and Method for Managing Storage Space of a Cache Formerly held Term ended Term ended May 15, 2021 · High confidence | Term ended | Term ended May 15, 2021 | High confidence |
| US 6,156,518 | Methods of using DNA encoding human alpha 1 adrenergic receptors Formerly held Term ended Term ended Dec 29, 2019 · From the USPTO record | Term ended | Term ended Dec 29, 2019 | From the USPTO record |
| US 6,300,087 | DNA encoding a human serotonin receptor (5-HT4B) and uses thereof Formerly held Term ended Term ended Nov 29, 2019 · From the USPTO record | Term ended | Term ended Nov 29, 2019 | From the USPTO record |
| US 6,713,265 | Methods of modifying feeding behavior, compounds useful in such methods, and DNA encoding a hypothalamic atypical neuropeptide Y/peptide YY receptor (Y5) Formerly held Term ended Ended no later than Sep 27, 2019 · From the USPTO record | Term ended | Ended no later than Sep 27, 2019 | From the USPTO record |
| US 6,221,660 | DNA encoding SNORF25 receptor Formerly held Term ended Term ended Aug 13, 2019 · From the USPTO record | Term ended | Term ended Aug 13, 2019 | From the USPTO record |
| US 6,124,331 | Selective NPY (Y5) antagonists (tricyclics) Formerly held Term ended Term ended Jun 30, 2019 · From the USPTO record | Term ended | Term ended Jun 30, 2019 | From the USPTO record |
| US 6,214,853 | Selective NPY (Y5) antagonists (bicyclics) Formerly held Term ended Term ended Jun 30, 2019 · From the USPTO record | Term ended | Term ended Jun 30, 2019 | From the USPTO record |